4
Changes in Ownership
AGIOS PHARMACEUTICALS, INC. Filed Acc 0001209191-18-045820
Chief Scientific Officer sold 3,000 shares at an average $80.11 ($240,333)
- Chief Scientific Officer acquired 3,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Biller Scott Chief Scientific Officer | 2018-08-06 | Option exercise | +3,000 | $9.05 | $27,150 | 60,196 | D |
| Biller Scott Chief Scientific Officer | 2018-08-06 | Sale | −300 | $78.32 | $23,496 | 59,896 | D |
| Biller Scott Chief Scientific Officer | 2018-08-06 | Sale | −2,100 | $80.15 | $168,315 | 57,796 | D |
| Biller Scott Chief Scientific Officer | 2018-08-06 | Sale | −600 | $80.87 | $48,522 | 57,196 | D |
| Derivatives | |||||||
| Biller Scott Chief Scientific Officer | 2018-08-06 | Option exercise · Stock options (right to buy) | −3,000 | 13,154 | D | ||
| Open-market sales · 3,000 sh · avg $80.11 · $240,333 | |||||||
Loading xslF345X03/doc4.xml…